A detailed history of Aqr Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aqr Capital Management LLC holds 2,676,296 shares of BMY stock, worth $142 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,676,296
Previous 2,348,472 13.96%
Holding current value
$142 Million
Previous $127 Million 12.73%
% of portfolio
0.17%
Previous 0.22%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $13.2 Million - $17.4 Million
327,824 Added 13.96%
2,676,296 $111 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $11.8 Million - $13.4 Million
246,701 Added 11.74%
2,348,472 $127 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $7.43 Million - $8.86 Million
-153,229 Reduced 6.8%
2,101,771 $108 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $37.9 Million - $42.4 Million
-654,731 Reduced 22.5%
2,255,000 $131 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $10.7 Million - $11.9 Million
168,024 Added 6.13%
2,909,731 $186 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $33.6 Million - $38.1 Million
511,072 Added 22.91%
2,741,707 $190 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $41 Million - $48.5 Million
598,538 Added 36.67%
2,230,635 $160 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $8,684 - $5.13 Million
66,803 Added 4.27%
1,632,097 $116 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $8.67 Million - $9.55 Million
119,402 Added 8.26%
1,565,294 $120 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $4.91 Million - $5.88 Million
-79,802 Reduced 5.23%
1,445,892 $106 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $1.7 Million - $1.98 Million
-31,691 Reduced 2.03%
1,525,694 $95.1 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $26.9 Million - $31.5 Million
-454,820 Reduced 22.6%
1,557,385 $92.2 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $45.7 Million - $49.8 Million
-738,957 Reduced 26.86%
2,012,205 $134 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $4.8 Million - $5.4 Million
-80,939 Reduced 2.86%
2,751,162 $173 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $22.6 Million - $25.6 Million
-391,849 Reduced 12.15%
2,832,101 $173 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $10.6 Million - $11.7 Million
-184,333 Reduced 5.41%
3,223,950 $193 Million
Q2 2020

Aug 17, 2020

SELL
$54.82 - $64.09 $34.3 Million - $40.1 Million
-625,065 Reduced 15.5%
3,408,283 $196 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $16.8 Million - $24.5 Million
363,125 Added 9.89%
4,033,348 $223 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $31.2 Million - $40.7 Million
633,429 Added 20.86%
3,670,223 $234 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $199 Million - $235 Million
-4,643,327 Reduced 60.46%
3,036,794 $154 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $36.6 Million - $40.5 Million
-820,972 Reduced 9.66%
7,680,121 $347 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $852,452 - $1.02 Million
-18,893 Reduced 0.22%
8,501,093 $400 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $112 Million - $145 Million
2,298,527 Added 36.95%
8,519,986 $443 Million
Q3 2018

Nov 15, 2018

BUY
$55.19 - $62.25 $55.9 Million - $63.1 Million
1,013,134 Added 19.45%
6,221,459 $386 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $94.2 Million - $117 Million
1,865,193 Added 55.79%
5,208,325 $288 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $43.7 Million - $50.3 Million
-729,867 Reduced 17.92%
3,343,132 $211 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $59.3 Million - $64.6 Million
988,731 Added 32.06%
4,072,999 $250 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $170 Million - $197 Million
3,084,268
3,084,268 $197 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.